Overview

18F-DOPA-PET in Planning Surgery in Patients With Gliomas

Status:
Active, not recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies fluorine F 18 fluorodopa (18F-DOPA)-positron emission tomography (PET) in planning surgery in patients with gliomas. New imaging procedures, such as 18F-DOPA-PET scan, may help find gliomas and may help in planning surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)
Treatments:
Dihydroxyphenylalanine
Fluorides